Sign inJoin waitlistJoin the waitlist

Olatoyosi Odenike

Professor of Medicine · University of Chicago Medical Center

Credentials: · · · ·

History

University of Chicago Medical Center
Present

University of Chicago Medical Center
1991–1993
Internal Medicine
University of Illinois College of Medicine at Chicago
1988–1991
UNIV OF IBADAN COLL OF MED, IBADAN, OYO STATE, NIGERIA
1984–1988

Research

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Blood · 2022 · 2,489 citations
International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT)
Review · Blood · 2006 · 275 citations
Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on…
Review · Leukemia Research · 2007 · 259 citations

Wendy Stock
72 papers
Richard Larson
54 papers
Lucy Godley
34 papers
Anand Patel
33 papers · 6 as a fellow
Andrew Artz
31 papers
Koen van Besien
22 papers · 4 as a resident
Uma Borate
21 papers
Hongtao Liu
20 papers
Michael Savona
18 papers
Michael Thirman
18 papers
Amer Zeidan
17 papers
Gail Roboz
17 papers

Clinical trials

A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms
Principal investigator · Withdrawn · Phase 1
University of Chicago
2021–2023
Study of Venetoclax in Combination With Decitabine in Subjects With Acute Myeloid Leukemia
Principal investigator · Active not recruiting · Phase 1
University of Chicago
2019–2027
Selumetinib and Azacitidine in High Risk Chronic Blood Cancers
Principal investigator · Recruiting · Phase 1
University of Chicago
2018–2027
Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous Leukemia
Principal investigator · Terminated · Phase 1, Phase 2
OncoTherapy Science, Inc.
2016–2021